The importance of real-world evidence in transforming healthcare decision-making
Over the last 20 years, US healthcare has shifted to a value-based system, with payers and healthcare providers being challenged…
Over the last 20 years, US healthcare has shifted to a value-based system, with payers and healthcare providers being challenged…
According to GlobalData, industry-sponsored trials have increased from 7,721 in 2016 to 13, 685 in 2025. This growth over the…
Marketing has evolved significantly since the time when a marketing plan would ignore market segment differences and appeal to the…
Growth in LBP production can be attributed to well-defined regulatory pathways in regions such as the US and EU, advancements…
The brand-new edition of the 2026 Clinical Research Report examines key therapy areas and deep dives into the latest advances…
Author: Manny Vazquez, Senior Director Clinical Data Strategy, Veeva The number of data points collected in clinical trials has tripled…
This year’s congress showcased remarkable progress across multiple fronts, from next-generation immunotherapies and antibody-drug conjugates (ADCs) to the accelerating role of AI-driven…
The growing friction between the US and China has serious consequences for the supplies of high-potency active pharmaceutical ingredients (HPAPIs),…
Parkinson’s Disease is a complex, progressive neurological condition which requires challenging, multi-modal endpoint assessment across both motor and non-motor symptoms.…
In the fast-paced environment of pharmaceutical innovation, bioconjugation has proved to be a cornerstone technology. By enabling the precise modification…